{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:04:40Z","timestamp":1762160680317,"version":"build-2065373602"},"reference-count":71,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2007,10,11]],"date-time":"2007-10-11T00:00:00Z","timestamp":1192060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND.<\/jats:title><jats:p>A considerable body of evidence supports the concept that a significant number of cutaneous malignant melanomas progress through a precursor lesion or dysplastic melanocytic nevi (DN). Tumor angiogenesis likely plays a critical role in early development of melanoma, and intermediate biomarkers of angiogenesis could be useful as chemoprevention and prognostic markers.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS.<\/jats:title><jats:p>Markers of angiogenesis that included expression of the vascular endothelial growth factor A (VEGF\u2010A) and microvessel density counts (MVD) were evaluated in 13 prospectively collected benign nevi (BN) and 19 DN from 16 individuals and in a comparison group of 17 primary melanomas (16 archival samples and 1 prospective melanoma).<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS.<\/jats:title><jats:p>VEGF expression in melanocytic cells (mean \u00b1 standard error [SE]) was low or absent in BN (3.4 \u00b1 1.4), increased significantly in DN (41.0 \u00b1 10.1; <jats:italic>P<\/jats:italic> = .0003 for BN vs DN), and increased further in primary melanoma (119.9 \u00b1 28.3; <jats:italic>P<\/jats:italic> = .06 for DN vs melanoma). MVD using CD31 (mean \u00b1 SE [percentage \u00d7 intensity]) followed a similar pattern with similarity between BN (2.6 \u00b1 0.7; N = 13) and DN (2.2 \u00b1 0.8; N = 19; <jats:italic>P<\/jats:italic> = .4 for BN vs DN), whereas primary melanomas were significantly higher (39.4 \u00b1 6.4; N = 17; <jats:italic>P<\/jats:italic> = .0001 for BN or DN vs melanoma).<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS.<\/jats:title><jats:p>In a prospective setting, the current data suggested that increased VEGF\u2010A expression in DN may be a good indicator of preneoplastic change in melanocytic lesions with the potential for improving the understanding and prevention of the transformation of DN to melanoma. Cancer 2007. \u00a9 2007 American Cancer Society.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.23076","type":"journal-article","created":{"date-parts":[[2007,10,11]],"date-time":"2007-10-11T13:09:06Z","timestamp":1192108146000},"page":"2519-2527","source":"Crossref","is-referenced-by-count":42,"title":["Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression"],"prefix":"10.1002","volume":"110","author":[{"given":"Janine G.","family":"Einspahr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy L.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathylynn","family":"Saboda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Nickolof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Warneke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Curiel\u2010Lewandrowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Ranger\u2010Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Duckett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Bangert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Fruehauf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Alberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,10,11]]},"reference":[{"volume-title":"Cancer Facts and Figures 2007","year":"2007","author":"American Cancer Society","key":"e_1_2_6_2_2"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.57.1.43"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)80285-X"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/84.5.289"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/109019819902600304"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.50.4.215"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.55.1.10"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.16.3635"},{"key":"e_1_2_6_10_2","first-page":"275","article-title":"Malignant melanoma: a clinical review","volume":"63","author":"Brown TJ","year":"1999","journal-title":"Cutis."},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17951-3"},{"key":"e_1_2_6_12_2","first-page":"269","article-title":"Cutaneous melanoma: update on prevention, screening, diagnosis, and treatment","volume":"72","author":"Rager EL","year":"2005","journal-title":"Am Fam Physician."},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/107327480501200402"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.04.014"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-59410-6_11"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206444"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2004.019422"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.12.1620"},{"key":"e_1_2_6_19_2","first-page":"18","article-title":"The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi","volume":"10","author":"Elder DE","year":"1993","journal-title":"Semin Diagn Pathol."},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70149-C"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp023017"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70151-I"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19890115)63:2<386::AID-CNCR2820630231>3.0.CO;2-6"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(83)70171-4"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.1993.56"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540420035026"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.MP.0000082394.91761.E5"},{"key":"e_1_2_6_28_2","first-page":"582","article-title":"The black cancer\u2014malignant melanoma","volume":"72","author":"Weaver PC","year":"1976","journal-title":"Nurs Times."},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(98)90384-7"},{"key":"e_1_2_6_30_2","first-page":"306","article-title":"Dysplastic melanocytic nevi: a reproducible histologic definition emphasizing cellular morphology","volume":"2","author":"Rhodes AR","year":"1989","journal-title":"Mod Pathol."},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-200108000-00006"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0560.2001.280702.x"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-198908000-00006"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1991.tb00829.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-199510000-00007"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65011-0"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(20000415)86:2<255::AID-IJC16>3.0.CO;2-L"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(98)90221-0"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.7.882"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.7212"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI30102"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/jemt.10259"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-200308000-00007"},{"key":"e_1_2_6_44_2","first-page":"770","article-title":"Vascular endothelial growth factor expression in malignant melanoma: prognostic versus diagnostic usefulness","volume":"12","author":"Bayer\u2010Garner IB","year":"1999","journal-title":"Mod Pathol."},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2006.02123.x"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10888"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00199.x"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1177\/106689690401200206"},{"key":"e_1_2_6_49_2","first-page":"3728","article-title":"Mitogen\u2010actived protein kinase activation is an early event in melanoma progression","volume":"8","author":"Cohen C","year":"2002","journal-title":"Clin Cancer Res."},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-200502000-00007"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06883.x"},{"issue":"2","key":"e_1_2_6_52_2","first-page":"S19","article-title":"Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis","volume":"7","author":"Erhard H","year":"1997","journal-title":"Melanoma Res."},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.1997.tb01583.x"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11583"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH757>3.0.CO;2-G"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.49.1.407"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00046358"},{"key":"e_1_2_6_58_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199808000-00007"},{"key":"e_1_2_6_59_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11714"},{"key":"e_1_2_6_60_2","first-page":"81","article-title":"Independent association of angiogenesis index with outcome in prostate cancer","volume":"7","author":"Mehta R","year":"2001","journal-title":"Clin Cancer Res."},{"key":"e_1_2_6_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1789.2005.00632.x"},{"key":"e_1_2_6_62_2","first-page":"51","article-title":"Endoglin (cd105) and S100A13 as markers of active angiogenesis in endometriosis","volume":"5","author":"Hayrabedyan S","year":"2005","journal-title":"Reprod Biol."},{"key":"e_1_2_6_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2004.12.002"},{"key":"e_1_2_6_64_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.13.1.9"},{"key":"e_1_2_6_65_2","doi-asserted-by":"publisher","DOI":"10.1177\/106689690301100103"},{"key":"e_1_2_6_66_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.486"},{"key":"e_1_2_6_67_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1993.1106"},{"key":"e_1_2_6_68_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004320050325"},{"key":"e_1_2_6_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61688-4"},{"key":"e_1_2_6_70_2","first-page":"81","article-title":"Microvascular density, vascular endothelial growth factor immunoreactivity in tumor cells, vessel diameter and intussusceptive microvascular growth in primary melanoma","volume":"14","author":"Ribatti D","year":"2005","journal-title":"Oncol Rep."},{"key":"e_1_2_6_71_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930715)72:2<455::AID-CNCR2820720222>3.0.CO;2-8"},{"key":"e_1_2_6_72_2","first-page":"331","article-title":"Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma","volume":"67","author":"Barnhill RL","year":"1992","journal-title":"Lab Invest."}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.23076","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.23076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:32:05Z","timestamp":1760268725000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.23076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,11]]},"references-count":71,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1002\/cncr.23076"],"URL":"https:\/\/doi.org\/10.1002\/cncr.23076","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"type":"print","value":"0008-543X"},{"type":"electronic","value":"1097-0142"}],"subject":[],"published":{"date-parts":[[2007,10,11]]}}}